- Open Access
Computational prediction of inter-species relationships through omics data analysis and machine learning
BMC Bioinformaticsvolume 19, Article number: 420 (2018)
Antibiotic resistance and its rapid dissemination around the world threaten the efficacy of currently-used medical treatments and call for novel, innovative approaches to manage multi-drug resistant infections. Phage therapy, i.e., the use of viruses (phages) to specifically infect and kill bacteria during their life cycle, is one of the most promising alternatives to antibiotics. It is based on the correct matching between a target pathogenic bacteria and the therapeutic phage. Nevertheless, correctly matching them is a major challenge. Currently, there is no systematic method to efficiently predict whether phage-bacterium interactions exist and these pairs must be empirically tested in laboratory. Herein, we present our approach for developing a computational model able to predict whether a given phage-bacterium pair can interact based on their genome.
Based on public data from GenBank and phagesDB.org, we collected more than a thousand positive phage-bacterium interactions with their complete genomes. In addition, we generated putative negative (i.e., non-interacting) pairs. We extracted, from the collected genomes, a set of informative features based on the distribution of predictive protein-protein interactions and on their primary structure (e.g. amino-acid frequency, molecular weight and chemical composition of each protein). With these features, we generated multiple candidate datasets to train our algorithms. On this base, we built predictive models exhibiting predictive performance of around 90% in terms of F1-score, sensitivity, specificity, and accuracy, obtained on the test set with 10-fold cross-validation.
These promising results reinforce the hypothesis that machine learning techniques may produce highly-predictive models accelerating the search of interacting phage-bacteria pairs.
Nowadays, the most-used therapeutic method to treat bacterial infections is the use of antibiotics. However, in recent years, this technique had to face resistance difficulties due to their overconsumption, which threatens medical progress . The increase in resistance makes it harder to fight bacterial infections, that is why alternative methods are required in the near future. The research required to discover new molecules, fueling novel antibiotics, in pharmaceutical laboratories usually implies long time, intensive work, and huge financial effort in comparison with the operating time before the occurrence of resistance. Phage-therapy is one of the most promising re-emergent therapies, consisting in the use of viruses, called bacteriophages, to infect and kill pathogenic bacteria along their life cycle with the aim of curing the infections they cause . These viruses have cohabited and evolved with bacteria, which, along the time, controlled the epidemics, bacterial population and, have contributed to their genetic exchanges since already billions of years. Phages or bacteriophages have the advantage to be extremely strain-specific and do not have a major impact on the commensal flora. The selection of a phage needs to be carefully done due to the fact that some of them can be used for a bacterial treatment but may also drive a horizontal gene transfer contributing to phage resistance.
The first experiments of phage-therapy started at the beginning of the 20th century, when bacteriophages were discovered . In the middle of that century, due to the antibiotics exploration, this therapy was set aside in western countries. Unfortunately, the overexploitation of antibiotics (human health, animal, agriculture,...) has allowed bacteria to develop resistances and, nowadays, the research of new antibiotic molecules is often longer than the time it takes some bacteria to adapt, causing these antibiotics to lose their effect. The concept of phage therapy involves correctly matching a bacterium and a phage able to interact with it. Currently, searching for these pairs is done experimentally in laboratories by means of infection tests , process that may take several days of labor. Many positive interactions have been uncovered using these tests revealing, for example, that highly phage-sensitive bacteria get infected by phages with both narrow and broad-host range, whereas highly phage-resistant bacteria are only infected by broad-range phages . There is an increasing number of studies focused on how phages can infect bacteria [6, 7] and on the defense mechanisms developed by bacteria against phage invasion . Receptor-binding proteins (RBPs) in phages are able to recognize and bind specifically to receptors on the surface of the bacterium. These bacterial receptors have been experimentally identified in some cases and shown to generally involve both proteins and cell-wall glycopolymers . When the phage is bound and connected with the bacterial host, it injects its genome inside the bacterial cytoplasm. Only the phage genome can enter in a target bacteria.
Phages can be classified in two categories according to the way their genome develops inside the bacteria: (1) Tempered phages that follow the lysogenic cycle, whose genome can integrate with the bacterium DNA, becoming a prophage that follows bacterial cell division. When the cell is under stress (e.g., cell damage), the prophage becomes active and initiate the “lytic cycle”. (2) Virulent, or lytic, phages, whose replication begins immediately after injecting their genome, resulting in bacterial wall disruption and destruction due to holins and lysins activity. Lytic phages are more suitable for phage therapy. A recent machine-learning approach, called PHACTS (Phage Classification Tool Set) , is able to automatically identify the type of life cycle of a phage based on its protein sequence.
Bacteria and phage constantly adapt their defense and attack mechanisms [6, 7]. One method used by bacteria to prevent phage attack is to render their receptors unrecognizable for the phage through mutations on them. Another mechanism is to hide the receptors’ binding regions with capsules as physical barriers . They may also develop the ability to block phage DNA injection when a second phage is trying to infect them . Some bacteria are also able to detect genetically-encoded sites that could be targeted by a restriction-modification system which cuts stranger DNA at specific recognition sites (e.g., the CRISPR/Cas system, evolved by bacteria, is a kind of prokaryotic immune system that confers resistance to a phage). Some bacteria choose to suicide to prevent their replication and to avoid any type of reproduction (abortive infection system ). Finally, phages can be defeated by bacteria through phage assembly interference, where bacteria encode phage-inducible chromosomal islands capable of negatively interacting with the assembly of the phage .
Thus, the host range of a phage not only depends on its own attack mechanisms: receptor-binding and lysins, but also on the bacterial defense mechanisms. Naturally, phages found in man-made and/or natural environments co-evolve quickly with their bacterial target. In consequence, the infectivity of a phage may differ from one host bacterial species to another and even from one strain to another of the same bacterial species . Currently, the host range of a phage is determined by means of infection tests  usually based on spot assays or, more recently, on methods such as microfluidic-PCR or PhageFish [13, 14]. All these methods, depending on the number of bacterial hosts tested, may require several days of laboratory work.
As already mentioned, phage-therapy is one of the most promising alternatives to fight against the emergence of multi-resistant bacteria. Usually, phage-therapy is performed by using cocktails of different phages able to kill a specific population of bacteria . These cocktails contain both lytic phages able to lyse the bacteria from outside  and temperate phages that add extra genes to the bacteria making them to lose their resistance, allowing thus to treat the patient with normal antibiotics [16, 17]. Several preclinical and veterinary trials  have shown good results but, unfortunately, phage-therapy still requires having a completely-characterized phage library as well as methods able to quickly detect a potential phage collection for a specific bacterial strain. A recent work by Volddby Larsen et al.  proposes a computational approach and a companion bioinformatic tool named HostPhinder, that deals partially with this goal as it predicts the bacterial host of a given phage based on its genome, by computing its similarity with the genomes of other phages with known host. There exist other approaches able to detect a phage-host range. For instance, Coelho et al.  propose a method based on PPIs, and Edwards et al.  propose a method based on sequence similarity resorting to techniques like Blast. Computational modeling-based approaches like PHAST (PHAge Search Tool)  are able to detect if a given bacteria contains a prophage using genomic information and BLAST matching to a phage-specific sequence. All these methods are based on sequence similarity to make their predictions.
This is where our approach steps in, as it might be used to automatically identify, from a phage library, a number of candidate phages able to infect a given pathogenic bacterium based mainly, or solely, on their genomes. To achieve this, we combine state-of-the-art techniques from machine-learning and bioinformatics with genomic data and the ever-growing information about phage-bacteria interactions. We conceived, explored and implemented an original approach, based on supervised modeling, to predict if a given phage-bacterium pair would interact. To build such predictive models based exclusively on genomic information, one of the biggest challenges resides in the, so-called, feature engineering. It consists in, first extracting informative features that capture essential properties of the phage and the bacterium. Then, in further selecting a subset of these features that allow the models to obtain the best predictive results.
Creation of the dataset
To create our training dataset, we extracted phage-bacterium pairs that have been annotated in public databases as exhibiting (positive) interactions. In order to complete the training dataset, we generated putative non-interacting (i.e., negative) pairs, since the public databases do not clearly annotate the absence of interaction. Two public databases were used to collect the complete genomes of all bacteria and phages: PhagesDB  and GenBank , consulted in February 2016. We compiled 1064 phage sequences—79 from GenBank and 986 from PhageDB—as well as 42 host bacteria sequences, extracted from GenBank. It results, thus, in a total of 1064 positive phage-bacterium interactions.
As mentioned above, we obtained a first set of 986 complete phage genome sequences from PhageDB . From this data we performed gene prediction, so as to retrieve coding-DNA and protein sequences, using GeneMarkS . We retrieved a second set of 79 phage sequences from GenBank accessed through the Entrez Nucleotide service [23, 24] which provides directly the genome, coding-DNA, and protein sequences. (The query ‘phage [Title] and complete genome’ was used to obtain the information for each phage.)
We parsed the annotation of each phage to obtain its bacterial host, by extracting it from the fields ‘Isolation Host’ and ‘host’, respectively, in PhagesDb and GenBank. The genome, coding-DNA, and protein sequences, for each bacterium, were extracted with the Entrez Nucleotide service, using the query ‘name of bacteria [ORGN] AND ‘complete genome’. All phages whose bacterial host was unknown or did not have a complete sequence were removed.
As already mentioned, the initial positive dataset contains 1064 phage-bacterium pairs with annotated interactions. Among them, 915 correspond to the same bacterial host (i.e., M. Smegmatis). Unfortunately, such over-representation of a single bacterium in the dataset may have a negative effect on the pertinence of the models obtained during the learning phase. In effect, a model based only on the presence or absence of M. Smegmatis to predict interactions. To palliate this effect, we grouped the interactions by bacterial families based on the NCBI’s taxonomy database  and further balanced their presence in the training dataset by means of oversampling—or replacement-sampling—a technique used to balance datasets containing classes with very different number of instances . We applied this technique to our positive interactions dataset using two steps: (1) grouping the interactions considering their bacterial families, we obtained 19 families with, in average, two bacteria. (2) replicating the interactions of each family as many times as necessary to ensure that it is represented around 300 times—excepting for the family containing M. Smegmatis. E.g, the family “Alteromonadaceae” which contains a total of four interactions (2 bacteria, each with two interactions) is replicated 75 times. This approach allows reducing the over-representation of M. Smegmatis. The oversampled dataset is composed by 6’517 interactions of which 915 involve M. Smegmatis, representing 14% of the interactions—against 86% for the original data.
Ideally, a negative dataset should contain phage-bacteria pairs that have been shown, experimentally, to not interact. Unfortunately, to the best of our knowledge, no data source provides such an information. For this reason, we created a set of putative negative interactions using all the phages and bacteria from the positive dataset. From all the possible phage-bacterium pairs, a given pair would be considered as not-interacting if it satisfies two conditions: (1) it does not exist in the positive set and (2) the bacterium belongs to a different species than that of the phage’s known host. Although, these criteria do not warrant that a given pair won’t interact at all, it will select pairs that are not known to physically interact and that are not likely to do it, considering the high specificity of phages to one bacterial species, even to specific strains within a species [27, 28]. This approach results in more than 43’000 putative negative interactions pairs. As before, in order to improve the relevance of the models extracted from the data, we decided to maintain the same number of negative pairs for each bacterial species than in the positive dataset. Whenever possible, these pairs are randomly selected from the putative negative set. In the case where the number of available negative pairs is not enough, some of them are repeated.
Feature extraction: Protein-Protein Interactions
The interactions between a phage and a bacterium are, in principle, mainly due to the interactions between their encoded proteins. So, one can expect protein-protein interactions (PPIs) to contain relevant information for predicting phage-bacterium interactions. In this section, we present the methodology used to extract two different sets of features, based on PPIs , that constitute the base for our candidate training datasets. In our database bacterial genomes encode, in average, for 3’417 proteins, whereas an average phage expresses 74 proteins, resulting in 74×3417≈2.5×105 PPIs for an average phage-bacterium pair. Note, nevertheless, that the number of PPIs may be (very) different from one phage-bacterium pair to another. In consequence, during the feature extraction stage, it is necessary to apply some kind of post-processing to make them comparable and easily exploitable by the machine learning algorithms. We extracted two kinds of features from these PPIs: domain-domain interaction scores and protein primary structure information, as explained below.
Domain-domain interaction scores
A domain is defined as a structural or functional subunit of a protein [29, 30]. Often, a PPI involves one or more bindings between pairs of their constituting domains. DOMINE  is a database of known and predicted protein domain interactions—or domain-domain interactions (DDIs). It contains DDIs observed in PDB crystal structures as well as those predicted by several computational approaches. In DOMINE, all DDIs are obtained using Pfam HMM profiles for protein domain definitions , to detect them in our proteins we used the HMMER API [32, 33]. Each DDI is evaluated by a quality score that represents the predicted quality of the interaction, computed by several algorithms. The cumulated interaction score of a PPI is then calculated as the sum of all its DDIs. Our database contains more than 2.2×105 proteins (from both bacteria and phages) with more than 3.5×105 domains. Using the scoring procedure described before, we obtain a vector of PPI scores for each phage-bacterium pair. To deal with the different vector lengths of these scores, we transformed them into a vector of frequencies (a histogram of PPI-scores) in order to obtain vectors of the same size. Doing so, we explored two parameters: (1) using normalized or absolute frequency, and (2) predefining the size of the histogram bins (SB) or their number (NB). We produced thus, four different kinds of datasets from the DDI scores, as described in Table 1.
Protein primary structure information
A second set of features is based on the physicochemical properties of the proteins of each PPI [34–37]. Using the sequence of each protein, we extracted the following 27 features: 21 representing the frequency of each amino-acid—i.e. the 20 amino-acids plus one for unknown amino-acids; five other features corresponding to the abundance of selected chemical elements composing the proteins (i.e. Carbon, Hydrogen, Nitrogen, Oxygen, and Sulfur)  and, finally, the molecular weight of the protein. So, for each protein-protein interaction, we have 54 features. As already mentioned, each phage-bacterium pair has, in average, more than 2.5×105 PPI scores, representing an extremely high dimensionality. In order to reduce it, we calculated, for each phage-bacterium pair, the mean and the standard deviation for the features across all its PPIs. At the end, each phage-bacterium pair is represented by 108 features, 54 mean values and 54 standard-deviation values.
In summary, 19 candidate datasets were created based on the two extracted types of features: 18 based on DDIs and one based on primary structure information, dubbed chemical composition (CH). A set of 13’034 phage-bacterium pairs, comprising an equal number of positive and negative interactions, was selected for feature extraction and to generate the datasets. Ten percent (10%) of the data was removed and used to create a stratified test set. For each bacteria family, the same proportion of interactions were taken into consideration for creating the train and the test sets. We then used a machine learning-based process, as described in next section, to investigate them and select the most informative datasets in order to constitute the final training dataset.
Predictive modeling and machine learning
We constructed a predictive model able to evaluate if a phage-bacterium pair can interact or not. Four machine-learning modeling techniques were explored in order to find their best configuration parameters as well as to identify the datasets that more consistently allow for the best prediction scores. These methods are: K-Nearest Neighbors (K-NN) , Random Forests (RF) , Support Vector Machines (SVM) , and Artificial Neural Networks (ANN) .
The modeling process was performed in two phases: exploration and refinement. The exploration phase allowed us to test multiple algorithm configurations performing a grid search with multiple parameter values for each modeling technique and for each dataset. The refinement phase extended the exploration of the number of neurons for ANNs on some selected datasets. Indeed, we noticed that their performance increased with such a number and required for further investigation. All along the process we used 10-fold cross-validation  in order to prevent model over-fitting and to optimize model selection. The predictive performance was assessed by using several metrics: accuracy, f-score, specificity, and sensitivity.
Given the large space of parameters explored for each algorithm, as well as the large number of datasets on which they were tested, we visualized all the results with heatmaps in order to better analyze them. Figure 1 shows, as an example, the heatmap of the F1-score results obtained in the exploratory phase. Note that during all the process we considered four performance metrics—i.e., sensitivity, specificity, accuracy, and F1 score to make the decisions.
At first sight, it seems that RF and K-NN attain excellent predictive performances while SVM and ANN are less predictive. However, such good results ask for special scrutiny and analysis:
K-NN: it bases its predictions on the similarity of each case (i.e., interaction) with its closest neighbors. As our dataset includes repetitions to reduce the over-representation problem of a bacterium, K-NN is fooled by this redundancy and obtains false high performances. This is clearly illustrated in Fig. 1 where it attains more than 96% of F1-score for almost any combination of dataset and k-values.
RF: It seems clear, from the very-high performance figures, often superior to 98% (see Fig. 1), that RF is also not performing well with repeating data. Indeed, as already reported in the literature, RF is closely related to K-NN and both can be viewed as weighted neighborhood schemes that make predictions by looking at the “neighborhood” of the target point .
SVM: From the results, we can observe that the best results are obtained on the datasets CH, SBN 1×10−6, NBN50, and NB50 when using small values for momentum and penalty. For those parameter configurations, the F1-score shown in Fig. 1 takes on values bigger than 85%.
ANN: Looking at the results in Fig. 1, the main conclusion we can make is that the more neurones are in the hidden layer, the better are the results. This is particularly visible for the four datasets mentioned above. One may obtain more than 88% of F-1 score with six neurones in hidden layer.
Considering these results, we decided to maintain four datasets—SBN 1×10−6, NBN50, NB50 and CH for further experiments. Note that the performances obtained on the CH dataset are so high that one could consider it as over-fitting. We decided, however, to keep it and validate such hypothesis on the final test set (i.e., the one never used for training nor validation).
From the previous analysis we can conclude that the number of hidden neurons in ANN is the only parameter that deserves further investigation. Figure 2 shows the F1-score results obtained for the additional configurations described in Table 2. Although the performance continued to increase with the number of neurons in the hidden layer, it stagnated with around 9 or 10 neurons. The F1-score reached 93% for the best configuration with the selected datasets. Note that the refinement phase was performed only on ANN as it is the only method whose results in the exploring phase are not conclusive enough. As already discussed, K-NN and RF overfitted the data and do not deserve more exploration. On the other hand, observing the SVM results, the parameter values allowing for the best performances are clear making it unnecessary to explore more configurations.
Based on the analysis of all the results, we selected as the best configuration the use of an ANN with 9 neurons in the hidden layer, trained during 50 epochs with 0.1 of momentum value and 0.01% as learning rate. The 10 models obtained by cross-validation during the refinement phase were evaluated on the test set (i.e., a set that was kept apart since the beginning and was never used during the modeling phases). Table 3 summarizes the results obtained on such tests. As expected, the performance figures on the test set are lower than those on the validation sets for all selected datasets. Nevertheless the performance loss is relatively small—e.g., accuracy loss ranges from around 4.7% for SBN 1×10−6 to around 1.1% for CH.
The emergence of antibiotic-resistant bacteria is a serious threat for medicine and health care. Phage-therapy, i.e., the use of viruses (phages) to fight bacteria, is a promising alternative to heal patients suffering of antibiotic-resistant infections. The main challenge for such therapy is to rapidly and effectively find the correct phage (or a handful of them) able to attack the target bacterium. To address this challenge, we explored the use of machine learning techniques to build models able to predict if a given phage-bacterium pair would interact, based on the genome sequences of both organisms. In order to train the models, our approach first builds a number of training datasets based on informative features obtained from the genomic data. For this purpose, we concentrated our analysis on protein-protein interactions and extracted, for each PPI, two types of features: one based on domain-domain interactions and another on chemical composition. Subsequently, we explored several machine-learning techniques on all these datasets in order to select a configuration (i.e., an algorithm and its parameter values) producing the most predictive models. The results obtained, with accuracy values ranging from 86% to almost 90% on test data, are encouraging.
Note that it is hard to make a direct comparison between the present work and our early approach. Indeed, as already explained, an oversampling was applied to our data so as to palliate the problem of the M. Segmatis bacterium being over-represented in the original dataset. As a consequence of this modification, K-NN and RF became unusable because of the repeats. The classification performances obtained on this new dataset are similar to those obtained previously, meaning that the other methods were able to adapt to the new data distribution. Another major difference with the previous results is the classification performance obtained on the CH dataset. This is due to the fact that this dataset is no longer based on principal component analysis, as this technique didn’t convey enough information to be predictive, but it is now calculated as the mean and the standard deviation of each feature.
Thanks to the experience acquired, we have identified the following issues that we should address in the future.
A first improvement should relate with the number and the diversity of the phage-bacterium pairs included in the database. Indeed, our positive dataset contains only 1’064 positive interactions, from which 915 were based on the same bacterial species (M. Segmatis) creating a serious bias on the data and limiting the predictive power of the models. The dataset should be enriched with more interaction pairs involving other bacteria. In the same sense, only a few pairs of our current data correspond to different strains of the same bacterial species. In consequence, it is not currently possible to make predictions at the strain level. We plan to add more strain-specific interactions to our database;
We will also consider two alternative strategies to avoid repeating interaction pairs in the dataset. In a first approach, we may under-sample the positive interactions containing M. Smegmatis so as to generate several small-but-balanced, training datasets. Then, obtaining classifiers for each dataset and, finally, combining them in a single ensemble-classifier. A second alternative would be to assign weights to each phage-bacterium pair inversely proportional to the relative frequency of its bacterium. In that way, those pairs containing M. Smegmatis would contribute much less to the global error while learning the classifiers;
Finally, another limitation concerns the current relevance of the features that depend on the DOMINE database, as its last release dates back to 2007.
In conclusion, the present work showed the potential of using machine-learning methods to predict if a given phage-bacterium pair will interact. The increasing amount of annotated interactions and that of available bacterial and viral genomes, together with advances in the comprehension of phage biology, leads us to think that we will soon have enough information to develop novel in silico tools that accurately predict phage-bacterium interactions. Such tools would contribute to the development of personalized therapies against bacterial infections and will reduce the time required to search for such a treatment.
Some ideas we are planning to further investigate include (1) performing “one-class learning” based only on validated positive interactions, (2) using reinforcement-learning, which is based on a reward system used alongside the training process, to drive the identification of genetic code relevant for phage-bacterium interaction, and (3) applying sequence-oriented machine learning techniques to learn directly from the genetic sequences instead of, or in addition to, extracted features.
Artificial neural network
Number of bins
Number of bins normalized
Size of bins
Size of bins normalized
Support vector machine
Lu TK, Koeris MS. The next generation of bacteriophage therapy. Curr Opin Microbiol. 2011; 14(5):524–31. https://doi.org/10.1016/j.mib.2011.07.028.
Matsuzaki S, Rashel M, Uchiyama J, Sakurai S, Ujihara T, Kuroda M, Imai S, Ikeuchi M, Tani T, Fujieda M, et al.Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases. J Infect Chemother. 2005; 11(5):211–19. https://doi.org/10.1007/s10156-005-0408-9.
Dublanchet A, Fruciano E. Brève histoire de la phagothérapie. Méd Mal Infect. 2008; 38(8):415–20. https://doi.org/10.1016/j.medmal.2008.06.016.
Weitz JS, Poisot T, Meyer JR, Flores CO, Valverde S, Sullivan MB, Hochberg ME. Phage–bacteria infection networks. Trends Microbiol. 2013; 21(2):82–91. https://doi.org/10.1016/j.tim.2012.11.003.
Beckett SJ, Williams HTP. Coevolutionary diversification creates nested-modular structure in phage-bacteria interaction networks. Interf Focus. 2013; 3(6):20130033. https://doi.org/10.1098/rsfs.2013.0033.
Labrie SJ, Samson JE, Moineau S. Bacteriophage resistance mechanisms. Nat Rev Microbiol. 2010; 8(5):317–27. https://doi.org/10.1038/nrmicro2315.
Samson JE, Magadán AH, Sabri M, Moineau S. Revenge of the phages: defeating bacterial defences. Nat Rev Microbiol. 2013; 11(10):675–87. https://doi.org/10.1038/nrmicro3096.
Seed KD. Battling phages: How bacteria defend against viral attack. PLoS Pathog. 2015; 11(6). https://doi.org/10.1371/journal.ppat.1004847.
Rakhuba DV, Kolomiets EI, Dey E, Novik GI. Bacteriophage receptors, mechanisms of phage adsorption and penetration into host cell. 2010; 59(3):145–155.
McNair K, Bailey BA, Edwards RA. PHACTS, a computational approach to classifying the lifestyle of phages. Bioinformatics. 2012; 28(5):614–8. https://doi.org/10.1093/bioinformatics/bts014.
Ram G, Chen J, Kumar K, Ross HF, Ubeda C, Damle PK, Lane KD, Penades JR, Christie GE, Novick RP. Staphylococcal pathogenicity island interference with helper phage reproduction is a paradigm of molecular parasitism. Proc Natl Acad Sci. 2012; 109(40):16300–5. https://doi.org/10.1073/pnas.1204615109.
Flores CO, Meyer JR, Valverde S, Farr L, Weitz JS. Statistical structure of host-phage interactions. Proc Natl Acad Sci. 2011; 108(28):288–97. https://doi.org/10.1073/pnas.1101595108.
Villarroel J, Kleinheinz K, Jurtz V, Zschach H, Lund O, Nielsen M, Larsen M. HostPhinder: A phage host prediction tool. Viruses. 2016; 8(5):116. https://doi.org/10.3390/v8050116.
Edwards RA, McNair K, Faust K, Raes J, Dutilh BE. Computational approaches to predict bacteriophage–host relationships. FEMS Microbiol Rev. 2015; 40(2):258–72. https://doi.org/10.1093/femsre/fuv048.
Fischetti VA. Bacteriophage lysins as effective antibacterials. Curr Opin Microbiol. 2008; 11(5):393–400. https://doi.org/10.1016/j.mib.2008.09.012.
Edgar R, Friedman N, Molshanski-Mor S, Qimron U. Reversing bacterial resistance to antibiotics by phage-mediated delivery of dominant sensitive genes. Appl Environ Microbiol. 2011; 78(3):744–51. https://doi.org/10.1128/aem.05741-11.
Yosef I, Kiro R, Molshanski-Mor S, Edgar R, Qimron U. Different approaches for using bacteriophages against antibiotic-resistant bacteria. Bacteriophage. 2014; 4(1):28491. https://doi.org/10.4161/bact.28491.
Coelho ED, Arrais JP, Matos S, Pereira C, Rosa N, Correia M, Barros M, Oliveira J. Computational prediction of the human-microbial oral interactome. BMC Syst Biol. 2014; 8(1):24. https://doi.org/10.1186/1752-0509-8-24.
Zhou Y, Liang Y, Lynch KH, Dennis JJ, Wishart DS. PHAST: A fast phage search tool. Nucleic Acids Res. 2011; 39(suppl):347–52. https://doi.org/10.1093/nar/gkr485.
Russell DA, Hatfull GF. Phagesdb: the actinobacteriophage database. Bioinformatics. 2016; 33(5):784–6. https://doi.org/10.1093/bioinformatics/btw711.
Benson DA, Clark K, Karsch-Mizrachi I, Lipman DJ, Ostell J, Sayers EW. Genbank. Nucleic Acids Res. 2013; 42(D1):36–72. https://doi.org/10.1093/nar/gkt1030.
Besemer J. Genemarks: a self-training method for prediction of gene starts in microbial genomes. implications for finding sequence motifs in regulatory regions. Nucleic Acids Res. 2001; 29(12):2607–18. https://doi.org/10.1093/nar/29.12.2607.
NCBI. Nucleotide. https://www.ncbi.nlm.nih.gov/nucleotide/. Accessed Aug 2017.
Entrez Help. https://www.ncbi.nlm.nih.gov/books/NBK3837/. Accessed Aug 2017.
NCBI. Taxonomy. https://www.ncbi.nlm.nih.gov/taxonomy. Accessed 2017 Aug.
Han J, Kamber M. Data Mining: Concepts and Techniques.Amsterdam: Morgan Kaufmann; 2012.
Duckworth DH, Gulig PA. Bacteriophages: potential treatment for bacterial infections. Biodrugs Clin Immunotherapeutics Biopharmaceuticals Gene Therapy. 2002; 16:57–62.
Ben-Hur A, Noble W. Choosing negative examples for the prediction of protein-protein interactions. BMC Bioinformatics. 2006; 7(Suppl 1):2. https://doi.org/10.1186/1471-2105-7-s1-s2.
Parham P, Masson PL. Le système immunitaire. Paris: De Boeck Université; 2003.
Terrapon N. Seeking divergent protein domains with Hidden Markov Models: application to Plasmodium falciparum. 2010. Theses, Université Montpellier II- Sciences et Techniques du Languedoc. https://tel.archives-ouvertes.fr/tel-00811835. Accessed May 2017.
Raghavachari B, Tasneem A, Przytycka TM, Jothi R. Domine: a database of protein domain interactions. Nucleic Acids Res. 2007; 36(Database). https://doi.org/10.1093/nar/gkm761.
Sonnhammer E, Eddy S, Birney E, bateman A, Dubrin R. Pfam: multiple sequence alignments and hmm-profiles of protein domains. Nucleic Acids Res. 1998; 26(1):320–22. https://doi.org/10.1093/nar/26.1.320.
Eddy SR, Wheeler TJ. HMMER User’s Guide. Maryland: HHMI; 2015. pp. 70–77.
Bock JR, Gough DA. Predicting protein-protein interactions from primary structure. Bioinformatics. 2001; 17(5):455–60. https://doi.org/10.1093/bioinformatics/17.5.455.
Shen J, Zhang J, Luo X, Zhu W, Yu K, Chen K, Li Y, Jiang H. Predicting protein-protein interactions based only on sequences information. Proc Natl Acad Sci. 2007; 104(11):4337–41. https://doi.org/10.1073/pnas.0607879104.
Xia J-F, Han K, Huang D-S. Sequence-based prediction of protein-protein interactions by means of rotation forest and autocorrelation descriptor. Protein Pept Lett. 2010; 17(1):137–45. https://doi.org/10.2174/092986610789909403.
You Z-H, Zhu L, Zheng C-H, Yu H-J, Deng S-P, Ji Z. Prediction of protein-protein interactions from amino acid sequences using a novel multi-scale continuous and discontinuous feature set. BMC Bioinformatics. 2014; 15(Suppl 15). https://doi.org/10.1186/1471-2105-15-s15-s9.
Carey F, Giuliano R. Organic Chemistry. New York: McGraw-Hill; 2014. pp. 1153–1199.
Cover T, Hart P. Nearest neighbor pattern classification. IEEE Trans Inf Theory. 1967; 13(1):21–7. https://doi.org/10.1109/tit.1967.1053964.
Breiman L. Machine learning. Mach Learn. 2001; 45(1):5–32. https://doi.org/10.1023/a:1010933404324.
Witten I, Frank E, Hall M. Data Mining: Practical Machine Learning Tools and Techniques. Burlington: Morgan Kaufman; 2013. pp. 351–372.
Lin Y, Jeon Y. Random forests and adaptive nearest neighbors. J Am Stat Assoc. 2006; 101:578–590.
This project is funded by the Swiss National Science Foundation (FNS) [Grant number: CR31I3_166124]. Publication costs were funded by the Swiss National Science Foundation (FNS) [Grant number: CR31I3_166124].
Availability of data and materials
Scripts and data (https://drive.switch.ch/index.php/s/uoBpjvY6dnxzrAf) — This folder contains all the dataset and scripts to execute the machine-learning methods.
About this supplement
This article has been published as part of BMC Bioinformatics Volume 19 Supplement 14, 2018: Selected articles from the 5th International Work-Conference on Bioinformatics and Biomedical Engineering: bioinformatics. The full contents of the supplement are available online at https://bmcbioinformatics.biomedcentral.com/articles/supplements/volume-19-supplement-14.
Ethics approval and consent to participate
There were no animal or human subjects used in this research.
Consent for publication
There were no animal or human subjects used in this research.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.